Time Course of Improvement of Metabolic Parameters after a 12 Week Physical Exercise Programme in Patients with Type 2 Diabetes: The Influence of Gender in a Nigerian Population

Table 2

Clinical profile of the participants at baseline by gender.

Variable	Mean ± SD	Minimum	Maximum	95% CI
Fasting plasma glucose (mmol/L)
Male (𝑛=8)	8.9 ± 2.1	2.0	18.0	6.6–8.0
Female (𝑛=21)	10.6 ± 3.9	3.0	22.0	9.4–11.9
HBA1c (%)
Male (𝑛=8)	8.79 ± 2.69	6.38	11.06	8.22–9.14
Female (𝑛=21)	10.08 ± 1.72	7.20	13.60	9.55–10.61
Body mass index (Kg/m^2)
Male (𝑛=8)	29.6 ± 5.4	23.5	52.4	29.3–38.8
Female (𝑛=21)	35.8 ± 6.9	26.1	57.3	31.5–39.9
Waist circumference (cm)
Male (𝑛=8)	103.1 ± 11.1	75.0	141.0	98.5–106.8
Female (𝑛=21)	96.5 ± 8.6	76.0	101.0	89.2–98.6
Waist hip ratio
Male (𝑛=8)	0.95 ± 0.05	0.88	1.03	0.95–0.97
Female (𝑛=21)	0.91 ± 0.02	0.83	0.95	0.85–0.89
Percent body fat (%)
Male (𝑛=8)	33.24 ± 5.28	22.30	42.70	30.87–36.33
Female (𝑛=21)	37.91 ± 4.78	18.70	47.80	26.16–40.94
High density lipoprotein (mmol/L)
Male (𝑛=8)	0.76 ± 0.23	0.65	1.60	0.62–0.86
Female (𝑛=21)	0.71 ± 0.35	0.58	1.86	0.66–0.84
Low density lipoprotein (mmol/L)
Male (𝑛=8)	3.92 ± 0.79	1.30	5.60	3.53–4.02
Female (𝑛=21)	4.35 ± 1.10	1.58	6.37	2.74–4.82
Total cholesterol (mmol/L)
Male (𝑛=8)	7.17 ± 1.52	2.90	9.60	6.70–7.64
Female (𝑛=21)	8.22 ± 1.97	1.52	9.86	4.18–6.72
Triglyceride (mmol/L)
Male (𝑛=8)	1.9 ± 0.3	1.0	2.3	1.6–2.1
Female (𝑛=21)	2.3 ± 0.5	1.2	3.1	1.8–2.6
Systolic blood pressure (mmHg)
Male (𝑛=8)	165.0 ± 7.50	140.00	190.00	156.5–170.5
Female (𝑛=21)	160.0 ± 6.00	120.00	210.00	140.0–180.0
Diastolic blood pressure (mmHg)
Male (𝑛=8)	90.00 ± 8.30	75.00	110.00	80.0–95.0
Female (𝑛=21)	90.00 ± 10.5	80.00	100.00	90.0–95.0